Koyfin Home > Directory > Health Care > Kiniksa Pharmaceuticals Ltd > Total Debt / (EBITDA-CAPEX)

Kiniksa Pharmaceuticals Ltd Total Debt / (EBITDA-CAPEX) Chart (KNSA)

Kiniksa Pharmaceuticals Ltd annual/quarterly Total Debt / (EBITDA-CAPEX) from 2019 to 2020.
  • Kiniksa Pharmaceuticals Ltd Total Debt / (EBITDA-CAPEX) for the quarter ending September 09, 2020 was $0m a -115.23% increase of 0m year over year
  • Kiniksa Pharmaceuticals Ltd Total Debt / (EBITDA-CAPEX) for the last 12 months ending September 09, 2020 was $0m a -36.91% increase of 0m year over year
Other Ratios Metrics:
  • Kiniksa Pharmaceuticals Ltd Other Liabilities for the quarter ending September 09, 2018 was $0m
View Chart On Koyfin

Quarterly KNSA Total Debt / (EBITDA-CAPEX) Data

09/2020$0m
06/2020$0m
03/2020$0m
12/2019$0m
09/2019$0m
06/2019$0m
03/2019$0m

Annual KNSA Total Debt / (EBITDA-CAPEX) Data

2019$0m